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Evidence-based practice is a pillar of medicines optimisation and essential to modern 
healthcare. Pharmacists are more likely to incorporate evidence-based interventions in 
their practice if they are involved in research or have done a PhD. The main barriers to 
pharmacists participating in research are lack of protected income and lack of research 
experience. Fellowship programmes like the NIHR integrated clinical academic program 
provide Clinical Pharmacists with research experience and adequate funding to pursue 




To develop understandings of the experiences and challenges of clinical pharmacists in 
the UK that have done a PhD or studying for one, including those who have applied for 




A qualitative exploratory study. Fifteen semi-structured telephone interviews were used 
to explore the experiences of clinical pharmacists that had done or were doing a PhD. 
Thematic analysis was used to analyse the data manually. Findings were reported using 




Participants were eligible if they were a qualified clinical pharmacist that had done a 




Barriers and facilitators to obtaining funding: 
 
 The barriers were: a challenging NIHR application process due to a lack of research 
experience and an extensive application process. Facilitators were: Organisational and 
institutional support, Pharmacy research UK, NHS funding. 
 
Key experience and challenges of doing a PhD: 
 
 The key theme was the juxtaposition of the unstructured, autonomous nature of PhD 
research with the structured nature of delivering clinical pharmacy services. This theme 
was either described in a positive light or as a challenge. Self-determination was a key 
theme, but co-regulation from supervisors and peers was necessary. 
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How the PhD and NIHR fellowships influenced the future career of the student:  
 
Most participants expressed a desire for an integrated clinical academic role. An NIHR 
fellowship led to such a role for the successful applicant. Participants acknowledged the 
scarcity of suitable split roles in pharmacy and would choose academia over clinical 
practice. The PhD equipped participants with the skills to critically evaluate the primary 
literature in their fields. In addition to increased competence in conducting research, 





This project found that clinical pharmacists have a similar experience to other PhD 
candidates, but early career pharmacists whose highest academic credential was an 
MPharm degree found the lack of structure more challenging. NIHR awards are 
challenging to secure, but there are some institutional and organisational structures to 
support applicants. Due to the limited availability of clinical academic roles for 
pharmacists, sustaining the pipeline of research trained clinical pharmacists might 
become challenging as participants would choose a full-time academic career over 
clinical practice.  
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2   Introduction 
 
2.1 The need for research in healthcare organisations and 
professionals. 
 
Research activity is essential to the practice of individual clinicians and the 
performance of healthcare organisations (Downing et al., 2017). A 
systematic review of the literature on the effect of research activity on 
healthcare organisations showed a positive correlation between research 
participation, and patient outcomes(Clarke and Loudon, 2011). It was found 
that there was a higher implementation of evidence-based medicine by 
clinicians and organisations that undertook research (Clarke and Loudon, 
2011). While the consensus among pharmacists is that research is 
essential, they mostly carry out audits which do not contribute to improving 
clinical outcomes as much as clinical research(Lee et al., 2018). The 
Pharmacy profession does not prioritise research, leading to low student 
interest in pursuing careers in research and pharmacists not applying for 
research fellowships and postgraduate training(Parker et al., 2013). Due to 
the ageing population, 49% of people on medication are taking multiple 
drugs on a long-term basis(Gao et al., 2018) and 30-50% of these drugs 
are not used as intended (NICE, 2016, Gao et al., 2018). Hence, the need 
for pharmacists that are equipped to make evidence-based decisions.  
 
2.2 Barriers and facilitators to pharmacist participation in 
research. 
 
A systematic review found that the main barriers to pharmacist research 
participation were a lack of dedicated time, awareness of opportunities, 
research experience, competence, funding, training, mentorship and 
managerial support (Awaisu and Alsalimy, 2015). The main facilitators to 
undertaking research were the belief in the importance of research, interest 
in the research topic, and believing the research has a benefit to patients. 
One study suggested that the facilitators are mostly related to the individual 
- intrinsic while the barriers are mostly organisational factors - extrinsic 
(Pager et al., 2012). Another study on UK pharmacists found that some 
extrinsic barriers were mostly narrated by pharmacists who did not 
participate in research which suggests that some of these extrinsic barriers 
like lack of time and managerial support were perceived rather than 
experienced (Lowrie et al., 2015).   
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2.3 Research culture in UK pharmacists 
 
The NHS consultant pharmacist post has been created partly to strengthen 
the link between research and practice in Pharmacy; addressing the need 
for research capacity building and developing a workforce that is research 
aware (Department of Health, 2015). Consultant Pharmacists need to 
spend about a quarter of their time on research, by identifying gaps in the 
evidence base, developing suitable hypotheses to answer the questions, 
designing and evaluating research methodologies and contributing to 
clinical trials (Department of Health, 2015). There were only 70 consultant 
pharmacist posts in 2017 nationwide, and this is disproportionate to the 
requirement for clinical leadership from pharmacists in the NHS (Specialist 
Pharmacy Service, 2017). There are now 106 posts (RPS, 2020), but there 
is a need for about 600 posts nationwide (Specialist Pharmacy Service, 
2017).  
  
2.4 Building research capacity 
 
“A research fellowship is a directed, highly individualised, postgraduate 
training program designed to prepare the participant to function as an 
independent investigator”(ACCP, 2009). Fellowships are one avenue to 
overcome some of the factors such as lack of protected time and funding 
that are known to be barriers to participation in research (Awaisu and 
Alsalimy, 2015, Clough et al., 2017). The National Institute of Health 
Research (NIHR) is one organisation that provides research fellowships for 
clinicians. It is the largest funder of health and care research in the UK 
(NIHR, 2019). The NIHR academic clinical fellowship (ACF) was only 
available to doctors and dentists until the NIHR Integrated clinical academic 
programme (ICAP) was introduced in 2014 to provide a similar opportunity 
to other health care professionals including pharmacists 
 
NHS England is legally required by the Department of Health and Social 
Care to promote research and Evidence-Based Practice within its Trusts 
and clinical commissioning groups (NHS England, 2017). The NHS 
partners with stakeholders, including the (NIHR) and Health Education 
England (HEE) to develop research opportunities, enhance the skills of 
clinical-researchers and strengthen career pathways (NHS England, 
2017).The HEE-NIHR integrated clinical academic programme (ICAP) is a 
national research capacity building scheme that provides funding to 
healthcare professionals who wish to develop careers that integrate clinical 
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research and research leadership into their practice. The programme offers 
five different levels of awards, namely; internships, pre-doctoral clinical 
academic fellowship, clinical doctoral research fellowship, clinical and 
senior clinical lectureships, bridging schemes and mentorships (NIHR, 
2019). Obtaining funding for this program is highly competitive (Clough et 
al., 2017).To build research capacity within pharmacy professionals, there 
needs to be an understanding of the experiences of pharmacists that have 




This research project aims to explore the experiences of Clinical 
Pharmacists in England who have a PhD, those who are currently studying 
for a PhD, NIHR fellows who are Clinical Pharmacists and to document the 




 To understand the barriers and facilitators to obtain funding to study a 
PhD. 
 To understand the students’ experience of studying a PhD including 
the key challenges. 
 To understand how postgraduate training and NIHR fellowships 





An exploratory qualitative approach was adopted and reported against the 
consolidated criteria for reporting qualitative research (COREQ) guidelines 
to establish rigour and trustworthiness (Tong et al., 2007). A pilot interview 
was conducted on one of the participants to check the appropriateness of 
the interview guide included in appendix 1. No changes were made to the 
interview guide, and the pilot interview was included in the analysis. A 
Semi-structured interview was chosen as the data collection method to 
generate rich data relevant to the research question while providing 
flexibility to explore the unique perspective of individual participants (Barrett 
and Twycross, 2018). Telephone interviews were used to access a wider 
sample of participants and overcome geographical constraints. 
 
3.2 Ethics and data storage 
 
This project was approved by the Aston University Pharmacy Ethics Sub-
Committee (PESC). The recordings were stored securely on the university 
home drive and deleted from the recording device. 
 
3.3 Inclusion criteria 
 
Participants were eligible if: 
 
1. They were a qualified pharmacist.  
2. They had done a clinical pharmacy research PhD or currently 
studying for one 
3. They were employed by the NHS or were employed by the NHS 




A mixture of purposive and convenience sampling was used due to time 
constraints. Working with the project supervisor who has an extensive 
network of pharmacist-academics, Twitter was used to purposefully invite 
clinical pharmacists with a PhD or doing a PhD to participate in a 30-minute 
interview to explore their experiences. The first 15 eligible respondents with 
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the earliest availability were chosen due to time constraints. Pharmacists 
that had been awarded for NIHR fellowships were identified from a 
database (NIHR, 2019) and sent an email invitation to interview. It was 
anticipated that no new information would be gained after 12-15 





Participants were sent a participant information sheet attached in appendix 
2 explaining the purpose of the project and a consent form by email, and 
interviews were scheduled. Participants were sent a reminder 30 minutes 
before the scheduled interview time. They were reminded of the purpose of 
the study at the beginning of the interview.  
 
3.6 Data collection 
 
Telephone interviews were conducted between 17/02/2020 and 
11/03/2020, recorded using an Olympus digital recording device, 
anonymised and transcribed verbatim by the chief investigator using 
Microsoft Word. All transcripts were completely reviewed by the chief 
investigator for accuracy and to gain overall context. Interviews focused on 
exploring the participants PhD experiences, sources of funding and career 
aspirations. Transcription was done using a denaturalised approach, 
preserving the original features of participants speech (Davidson,2009). 
The quotes included in the report were ‘cleaned’ to keep to the word count. 
Participants were sent a link to a Microsoft forms document collecting 
necessary demographic data and (n=14) 87.5% of participants completed 
the form.  
 
3.7 Data Analysis 
 
Thematic analysis is “a method for identifying, analysing and reporting 
patterns (themes) within data”(Clarke and Braun, 2017). A digital 
adaptation of this method described below was adopted. 
 
1. All interviews were transcribed using Microsoft Word by the chief 
investigator thereby, facilitating initial familiarisation with the data 
corpus and potential themes were noted. 
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2. All transcripts were read and evaluated by the chief investigator, 
and provisional coding frames were noted. 
3. The provisional codes generated at this stage were assigned to 
the relevant data extracts by using the comment feature on 
Microsoft Word. 
4. Formal coding was done manually on a semantic level, identifying 
essential elements of the data that described the essence of a 
narrative. 
5. Data extracts that described the same narrative were highlighted 
in the same colour, using a different colour to indicate each code 
(multiple codes were assigned to some data extracts). 
6. Emphasis was placed on deviant narratives. 
7. Data extracts in the same highlighter colour were collated and 
assigned a code. 
8. All data extracts in the same colour were copied and pasted into 
a OneNote page to create a data set for that code. A data set 
refers to all instances within the data corpus where a specific 
code was referred to (Clarke and Braun, 2017).  
9. A participant identifier was assigned to all data extracts for 
reference and to show that a range of participants was included 
in the results.  
10. A page was assigned to all deviant narratives. 
11. Themes were derived inductively, meaning that they were 
purely derived from the data without the influence of any existing 
knowledge of the subject. 
12. The different codes were studied for similarities and grouped 
into provisional overarching themes.  
13. The provisional themes were analysed to ensure that the data 
extracts and codes within each theme created a logical narrative 
and that individual themes were genuinely distinguishable. 
14. The data was re-read critically, evaluating how it all fit into the 
defined themes and re-coding any data in the themes that were 
not initially coded. 
15. A theme map was used to graphically illustrate the relationship 
between themes and subthemes, with the overarching theme 
being the central element and the codes mapping out of the 
theme. 
16. Constant comparison was made, removing codes from themes 
and including new codes until there was a satisfactory connection 
between themes and codes and between the different themes. 
 13 





In Qualitative research and thematic analysis, themes are constructed 
through interactions with research participants, the data generated, and the 
data analysis is influenced by the engagement of the researcher (Dodgson, 
2019). Nicole Abrokwah is a female final year MPharm student at Aston 
University with a keen interest in undertaking a non-clinical pharmacy 
research masters in the future, going on to become a pre-registration 
pharmacist at a large multiple community pharmacy. The university has 
arranged all hospital pharmacy experience and a total of 48 hours 
compared to 1000 hrs in community pharmacy throughout the MPharm 
degree. This background may have facilitated a neutral interpretation of the 
views of the participants who were hospital pharmacists as the investigator 
has no immediate experience of either being a clinical pharmacist or a PhD 
student. A mobile note-taking app was used to capture views and 
interpretations throughout data collection. 
4 Results 
 
In analysing the interview data from fifteen participants which lasted an 
average of 26.5 minutes, six major themes and thirteen subthemes 
emerged to answer the three research questions. The sample included 
participants that were representative of twelve UK schools of pharmacy. 
One participant had been awarded an NIHR fellowship, and two 
participants had unsuccessfully applied for the NIHR doctoral training 
award. Five participants were still studying for their PhD while ten already 





age ethnicity gender NHS 
band 





White male 8b  Pharmacist and 
lecturer 
Y 





Other male n/a Lecturer Y 
P4 40-
50 
Asian female 8b  Pharmacist N 
P5 31-
40 










White female 8a NHS pharmacist N 
P8 >50 White female 8c Clinical Academic 
 
Y 





White female 8a Clinical academic N 
P11 41-
50 
White male 8c NHS pharmacist Y 
P12 31-
40 
White female 7 Clinical academic Y 
P13 31-
40 
White female n/a PhD student N 
P14 26-
30 





mixed Female 8b Pharmacist Y 
Table 1 – characteristics of interview participants 
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Barriers and facilitators to obtaining funding 





Long application process 
 







Supporting grant applications 
 
NHS research funding  
 
Pharmacy Research UK 
 
Table 2 Barriers and facilitators to obtaining funding 
 
Experience of doing a PhD and key challenges  
Themes Subthemes 
Juxtaposition of PhD 
and clinical practice 
 
 
Lack of structure 
Escape from monotony in clinical practice 
 
Isolation 
Motivation Self-determination and Co-regulation 
(extrinsic and intrinsic factors of motivation) 
 





How postgraduate training and NIHR fellowships influence the 
future career of the student 
Themes  Subthemes 
Pragmatic Practice Evidence-based practice 
 




Future aspirations Availability of suitable clinical 
academic posts 
 
Preference for academia over 
clinical practice 
 
Table 4 How Postgraduate qualifications influence the student's future career 
 
4.1 Barriers and facilitators to obtaining funding 
 
The sources of funding for participants in this project were: NHS charitable 
funds, NHS department funds, Pharmacy research UK, commercial 
funders, PhD loan, The NIHR and university employers. 
   
4.1.1 Challenging NIHR application process and protected income 
 
The NIHR awardee was the only participant in this study whose financial 
requirements were exhaustively covered by one funder. 
 
“I was really fortunate in that I did an NIHR funded fellowship, so I had my 
expenses, my salary was paid, my training costs were paid so I didn’t have 




Other participants had partial funding from multiple sources, including 
Pharmacy Research UK, which was a running subtheme. Most 
participants had to take a pay cut to do the PhD. 
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“So, initially I was funded by the trust...then I was encouraged to apply for 
external funding so I applied to pharmacy research and was 
successful ….there was a major cut in my income and I guess that’s one of 




“… I was really lucky to have a funded PhD, but the salary is quite low…so 
that can be quite difficult… I was encouraged to apply for small research 
grants during my PhD to supplement my research costs and salary so, that 




Participants were aware of the NIHR schemes and the consensus among 
participants was that NIHR fellowships are attractive opportunities 
compared to other sources of funding. 
 
“At the moment I’m looking to apply for the NIHR ICAF to provide me with 
the opportunity to go back and do more clinical practice and continue with 




4.1.1.1 Long application process 
 
The process of securing an NIHR award was described as extremely 
challenging and seemingly impossible by all relevant participants. There 
was a consistent reaction of nervous laughter, suggesting a recollection of 
distress and apprehension compared to when talking about other funders. 
This theme was consistent amongst all participants regardless of career 
stage.  
 
“...it was quite a torturous process…. the application itself probably took me 
about five months in total… working solidly outside working hours, so 
evenings and weekends… it certainly shouldn’t be taken lightly in terms of 





“…so, I got two young pharmacists this year applying for the pre-doctoral 




Unsuccessful participants said they received detailed feedback which likely 
facilitated the success of future applications to other funders. 
 
“…Because I could reflect on the feedback that I received from NIHR, I was 
able to improve my research project and also improve the application for 




4.1.1.2 Lack of research experience 
 
Having a track record of independently conducting research is a facilitator 
to securing funding. This participant was aware of the NIHR programmes 
but did not apply due to insufficient research experience. 
 
“I was aware that the NIHR have doctoral fellowships, but they’re very 
competitive, and you have to be somebody who is quite a senior clinician 
already and got some research under their belt, so I didn’t think I was going 




In comparison, this participant received full funding from her NHS Trust on 
her first application and did not need to consider other funding sources. 
 
“I’ve also been the principal investigator for several studies within the Trust, 




4.1.2 Organisational and institutional support 
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Support from the employing organisation or evidence of an employing 
organisation with resources in place to support the research is a facilitator 
to obtaining funding for research. This support includes supervisor support. 
 
“…I needed to be affiliated with a hospital and fortunately…. I had a clinical 
supervisor at the xxx hospital, so xxx hospital gave me an honorary 
contract for the duration of my PhD… it felt like doing the PhD was reliant 




4.1.2.1 Supporting grant applications 
 
The process of writing grant applications is challenging. Some participants 
had access to professional resources that reviewed their application and 
prepared them for the interview process.  
 
“Completing the grant application was new, and you needed to find out 
loads of information on how to do it, how to complete sections… where to 





“…I went into the university with my line manager and said I’m gonna apply 
for this grant…they did a mock interview and gave me feedback...that was 




The results from this project show that The Royal Pharmaceutical Society 
(RPS) provides such support to pharmacist researchers. 
 
“Pharmacy research UK was slightly easier maybe because I had done the 
NIHR application… it was for less money, so it was slightly easier to 
prepare the application and I got support from the RPS, they reviewed my 





There might be a lack of awareness of the availability of these resources to 
potential pharmacist researchers. On the other hand, only the more pro-
active individuals might make an effort to access the support available to 
them. 
  
“…if you ask research development in your hospital…you just don’t ask...all 
the barriers as pharmacists are just in our head…I know of a pharmacist 
that applied for research funding many times, and I said to her - the 
hospital she was at had a biomedical research centre I said why haven’t 




4.1.2.2 NHS funding 
 
The NHS funded most participants in this project either through funds held 
by the department, supervisor or through NHS charitable funds. 
 
“So, I started my PhD not long after I qualified as a pharmacist and my PhD 




In addition to financial support from the department, this participant 
received moral support from his manager. 
 
“…It was straightforward for me to be funded for this programme because 
my department had paid for it… I’ve always wanted to do a doctorate and 
when the opportunity came along to have it funded by my department and 




4.2  Experience of doing a PhD and key challenges 
 
4.2.1 The juxtaposition of the PhD experience with clinical practice 
 
Majority of participants in this study expressed the challenges of doing a 
PhD in comparison with being a clinical pharmacist. 
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4.2.1.1 Lack of structure during PhD 
 
Participants cited the transition from working in a hospital ward to becoming 
a PhD researcher as a key challenge.  
 
“…going from working in a hospital where you’ve got targets, you’ve got 
med recs to do, you’ve got TTOs to do, and you’re counselling to a PhD 
where there’s no rules really, your day is not structured and often you’ve 




“…because in clinical practice, everyone tends to work the same way with 
the same outcomes…targets like medicines reconciliation or prepping 
discharge that’s a set goal that you’re working towards each day on the 
ward there’s none of that within PhD life… you’re very much responsible for 




Some participants did not refer to the lack of structure as a challenge, and 
they had all done a research masters before the PhD 
 
“…I’ve done research right through the very start of my career in such a 





“… Got first research experience during MSc degree which was straight 




One participant speculated that other PhD candidates were better prepared 
to deal with the lack of structure because they had done a research 
masters. 
 
“…also learning how to do research as I hadn’t got any formal training and I 
felt that people I knew (not pharmacists) but other people who were doing a 
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PhD, I could see that those who were doing an MRes were better prepared 




4.2.1.2 Monotony in clinical practice 
 
Other participants considered the lack of structure described previously as 
a welcome challenge because it gave them a break from clinical practice. 
 
“ …I could see myself stagnating at the hospital and I was getting a bit 




…it’s a really positive experience …when you’re a pharmacist, you’re often 





Other participants had a narrative that indicated a subliminal sense of 
boredom and lack of intellectual stimulation including P1 who implicitly 
described this monotony at three different points during the interview. 
 
“My inclination to undertake a PhD has always been somewhere in the 
background… but never was really something I felt was particularly 
important until probably a bit later on when I’d done two post graduate 




“…Newly qualified clinical pharmacist came to xxx hospital which they 
thought was the best of the best and they got so depressed mostly at first, 
very bright kid just got so disillusioned doing TTOs discharge discharge 
discharge and not really being given the opportunity or being taught how to 





4.2.1.3 Isolation during PhD 
 
Isolation was a challenge reported by the participants and found to be a 
major theme both in terms of the frequency in the data corpus and the 
intensity with which some participants described it. 
 
“sometimes life was put on pause and you do feel slightly isolated when 
things aren’t going well with your project, but you just have to keep 




“But the challenge was the isolation that comes with that so you’re often 




4.2.2 Motivation, self-determination and co-regulation 
 
There were various sources of motivation to study a PhD found in this 
project. These sources will be classed as being intrinsic or extrinsic to the 
individual. 
 
Most participants reported a passion for research which is an intrinsic 
motivator. 
 




On further exploration, it was discovered that there were other motivators. 
 
“…it comes down to where you see yourself in your career… I saw a PhD 
as an option…to open up more doors for me…laughs… I also see the 
future of pharmacists like consultant pharmacists being pharmacists that 




Most participants claimed to be resilient, driven etc. 
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“…I’m quite driven… I think I don’t struggle as much with those challenges 
that I’ve mentioned …if you weren’t, I can imagine the PhD becoming a 




“… I have got a lot of stamina to stick things out through thick and thin and I 
am what they call a complete finisher.” 
 
P4 
One participant would not describe himself as being driven but was 
sufficiently motivated by extrinsic factors. 
  
“…I think the thing that got me through my PhD was that I wanted to 





In addition to being driven and self-determined, there was a need for 
external support from peers and supervisors. 
 
“…if you’re working with a team of other PhD students that support network 





“My main supervisor is fantastic; he’s so calming even when things are 
going very wrong and that has an impact on you…. he’s very supportive of 




4.3 How post-graduate training and NIHR fellowships influence 
the future career of the student 
 
These themes and subthemes describe the reflections of the participants 
on how their practice changed following a PhD. 
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4.3.1 Pragmatic practice 
 
All but one participant reported that they were more competent at various 
aspects of their jobs in addition to being more competent in conducting 
research. 
 
4.3.1.1 Evidence-based practice 
 
Participants were equipped to critically evaluate the literature in their 
specialisations and make evidence-based decisions in their practice. 
 
“I think I understand the research… I can apply all of the research that’s 




“…but when you engage in an academic process and you’re in clinical 
practice you realise…that it makes you a better pharmacist as far as the 
patients are concerned… to write a paper one had to review the literature, 




They were more comfortable with deviating from guidelines when 
appropriate and evaluating the primary literature when making decisions. 
 
“I’m used to dealing a with uncertainties… I’m probably able to practice 
more at a specialist level because of my research background…what I 
mean with the flexibility is confidence to deviate from guidelines when not 




In addition to being “a lot braver”, P1 was better at liaising with other 
members of the multidisciplinary team. Instead of relying entirely on 
guidelines, he was equipped to understand the limitations of the guidelines. 
This understanding effectively made him a better team member because 
he could work with other clinicians to make the best decision for a specific 
patient rather than making binary or algorithmic decisions. 
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“…when it comes to patient care I’m a lot braver…… say someone comes 
in with an acute kidney injury…we need to take them off metformin, 
lisinopril etc but someone on the team says keep them on metformin, I can 




4.3.1.2 Improved pedagogy 
 
Participants that had teaching roles at the university or in a hospital 
reported that they became better educators than they were.  
 
“I certainly look at things very differently now…and trying to innovate much 









4.3.1.3 Transferable skills 
 
This project found that a PhD confers skills that are not directly related to 
clinical practice or conducting research; Skills like collaboration, leadership, 
effective communication. 
 
“…my professional life has definitely grown especially in things like 
leadership and management… which you don’t tend to get any training…I 




“… I’m more confident and I can speak to anyone now…I can go on a ward 
round and talk to the consultants, registrar, specialist nurses, 





4.3.2 Future aspirations 
 
Majority of the participants in this study expressed a desire to have a mixed 
career in the future depending on the availability of a suitable position.  
 
“I’d quite like to be a professor…I think I’d still like to have my clinical 
practice as well…somewhere along the line if you become a professor you 




“I see myself having a split role initially after the PhD, working between 
academia and clinical practice… I really love spending time with patients 
and getting involved with the MDT…but I definitely don’t see myself doing it 




Some participants acknowledged that finding a suitable split position might 
be challenging. 
 
“…I’m not sure I would be able to find a clinical job which has a research 




Doing the NIHR doctoral fellowship led to a suitable split role for P2. 
 
“…I really just anticipate incorporating research in my day job role…using 
the skills that I acquired during the PhD...seeing it as part of my role rather 




A minority of participants wished to become full-time researchers.  
 
“I know for certain that I won’t go back to being a clinical pharmacist, I’d like 





“I think my skill sets suit academia better and I would like to stay in an 





This project found results that are similar to findings from other studies and 
the experience of clinical pharmacists doing a PhD is similar to the broader 
population of doctoral students. Findings suggest that the clinical 
pharmacist job role made the unstructured nature of PhD research 
particularly challenging for some participants. The most recent review of 
the literature on the experiences of doctoral students or PhD students 
found that the factors that affect a student’s completion and contribute to 
their PhD experience can be classified as being intrinsic or extrinsic. 
Extrinsic factors include supervisor support, personal/social lives and the 
department. On the other hand, inner processes (mental or psychological 
processes) that are immediately related to academic work such as 
motivation, writing skills, self-regulatory strategies and academic identity 
were classed as internal factors (Sverdlik et al., 2018).  
 
5.1 Challenging NIHR application process and organisational 
support 
 
Access to sufficient funding is an extrinsic factor shown to influence the 
experience and well-being of PhD candidates (Sverdlik et al., 2018). The 
findings from this project resonate with findings from the literature that lack 
of protected income is a barrier to pharmacists carrying out research or 
pursuing clinical academic careers (Awaisu and Alsalimy, 2015). The NIHR 
was the only funder where the participant did not have to take a pay cut to 
do a PhD. It is unlikely that higher-earning pharmacists would be able or 
willing to pursue a research career if their income was not protected. NIHR 
guidance suggests that applicants should dedicate between six to twelve 
months to write a competitive application (NIHR, 2020) which might be an 
impossible time commitment for most full-time pharmacists trying to 
balance work with other commitments.  
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The difficult NIHR funding journey is not peculiar to this project. In a survey 
of 231 non-medical health professionals including pharmacists that applied 
for research funding including NIHR fellowship schemes, there were 
several challenges associated with the funding application process, 
including the extensive and difficult application process, lack of feedback 
from failed applications, problems finding the right supervisors, support 
from the host organisations for the application process and a lack of 
funding opportunities (Richardson et al., 2019). In this project, the only 
common challenge was the extensive and difficult funding process, but the 
other challenges like organisational and institutional support were 
conversely described as facilitators. This contradiction is likely due to the 
sample size and small number of organisations represented in this study. 
 
Due to the prestigious nature of NIHR awards, the selection process is 
designed to identify the most capable applicants. Unlike professions like 
medicine where research is embedded with career progression, a lack of 
research culture and low research participation among pharmacists 
compared to other professions might be a hindrance to pharmacist 
applicants because NIHR guidance suggests that for a competitive 
application, applicants should be able to demonstrate a history of 
independently conducting research (NIHR, 2020). 
 
A systematic review on pharmacist participation in research found that lack 
of time and managerial support are external barriers that hinder 
participation in research(Awaisu and Alsalimy, 2015). Although hospital 
pharmacists were included in the systematic review, most of the studies 
were done on community pharmacists(Awaisu and Alsalimy, 2015). 
Organisational barriers such as lack of protected time and managerial 
support were not found in this project. Conversely, there was a theme of 
adequate managerial support. This echoes findings from a study on NHS 
pharmacists that these barriers are perceived rather than experienced 
(Lowrie et al., 2015).  
   
5.2 The Juxtaposition of the PhD experience with clinical 
practice 
 
A literature review on the experiences of doctoral candidates revealed the 
lack of structure as one of the most frequently reported challenges 
(Sverdlik et al., 2018). This theme is not unique to this project, but its 
prevalence in the context of comparison with clinical practice suggests that 
 30 
the clinical pharmacist job experience makes this lack of structure more 
challenging for early-career clinical pharmacists or those whose highest 
academic credential before the PhD was the MPharm. Participants who 
had done a research masters did not consider the unstructured nature of 
PhD research a challenge; these participants were band 8b-8c pharmacists 
which suggests that career stage could be a confounding factor. It has 
been suggested that the MSc in clinical pharmacy does not increase 
competence and research confidence in hospital pharmacists (Lowrie et al., 
2015) but the findings from this project suggest that a research masters 
could potentially ease the transition into a PhD programme.  
 
The MPharm is neither designed nor intended to prepare graduates for 
planning and conducting research - “The programme integrates science 
and practice and equips students with the theoretical knowledge, 
professional behaviours and clinical skills required to become a 
pharmacist.” (GPhC, 2020). PhD research involves a great deal of self-
direction compared to the standard undergraduate MPharm qualification 
possessed by most participants. NHS band 8b-8c pharmacists have to lead 
teams and manage others which potentially prepared the participants for 
the self-directed, autonomous and unstructured nature of PhD research. 
 
5.3 Self-Determination and motivation  
 
The self-determination theory of human motivation proposes that humans 
have three innate psychological needs; competence, autonomy and 
relatedness and that when these needs are met, optimal function, wellbeing 
and growth can be achieved (Deci and Ryan, 2008). This theory assumes 
that humans are naturally inclined to seek growth, and that intrinsic factors 
of motivation are more important than extrinsic factors to reach goals. 
Activities are defined as being intrinsically motivated if the individual 
engages in them purely out of interest and extrinsically motivated if the 
individual participates in them to obtain a reward that is separate from 
participating in that activity or in order to avoid negative consequences. In 
the context of this project, a participant is said to be intrinsically motivated if 
their main reason for doing a PhD was a passion for research and 
extrinsically motivated if their reason for doing a PhD was for reasons such 
as career progression, being invited to do a PhD by a senior academic, to 
boost their ego or sense of identity within the multidisciplinary team.  
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Intrinsic and extrinsic motivation can sometimes exist as separate entities 
that are completely internally or externally regulated but mostly not 
diametrically opposed (Deci and Ryan, 2000). There are extrinsic factors 
that can either enable or hinder the natural inclination to grow hence, the 
different types of motivation exist on a spectrum where external motivation 
is either completely regulated by external factors on one end, by external 
factors that have been internalised in the middle. Internal motivation being 
completely internally regulated on the opposite end. In this study, although 
the majority of participants reported an intrinsic motivator like a passion for 
research as found in a different study (Lowrie et al., 2015) as their primary 
motivation for doing a PhD, upon further exploration and analysis it became 
apparent that they were also motivated by extrinsic factors like career 
progression or having family members in academia. These extrinsic factors 
had been internalised to varying degrees, highlighting a continuum of 
regulatory styles. Due to social desirability bias, only P1, P3 and P15 
reported extrinsic factors as their main reason for doing the PhD. The data 
analysis confirms that motivation exists on a continuum. Contrary to the 
theory that intrinsic motivation is more important in achieving goals, 
participants in this project were sufficiently motivated by extrinsic factors. 
P2, who successfully applied for NIHR funding was a deviant case in terms 
of motivation to do a PhD as her primary motivation was to answer a 
research question that became obvious during clinical practice. Although 
P2 was a deviant case in this project, her primary motivation is in line with 
findings from studies on other NIHR awardees where 30% of health 
professionals did a PhD to “investigate a particular research question 
relating to clinical care provision” (Richardson et al., 2019.)  
 
5.3.1 Co-Regulation and isolation 
 
“Co-regulation of learning refers to a social regulation of learning in which 
learners temporarily regulate their cognition, behaviour, motivation and 
emotions together with other students or a teacher” (Raisanen et al., 2016). 
Self-direction is a crucial element in PhD and Doctoral studies across all 
disciplines (Lynch et al., 2018). Although participants in this project 
reported that they were sufficiently self-directed, the themes of isolation 
and supervisor support suggest that co-regulation was essential to their 
PhD experience. This finding echoes the findings from other studies where 
It has been found that social support might strengthen a student’s sense of 
professional identity as a researcher and their place in the research 
community (Mantai, 2019, Lowrie et al., 2015) and that support from the 
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supervisory team is a key element of successful doctoral studies (Devos et 
al., 2015). These results are not unique to clinical pharmacists as they are 
in line with the findings from a study on medical students that co-regulation 
from supervisors and peers contributes to self-regulated learning in medical 
students (Bransen et al., 2020). Some participants worked in NHS Trusts 
that organised meetings for doctoral and post-doctoral researchers and 
used this to fulfil their need for relatedness and peer support. On the 
academic side, some participants were part of PhD groups at their 
university.  
 
5.4 Pragmatic Clinical Practice and Critical appraisal skills 
 
Studies have shown that health care professionals and organisations that 
are research active are more likely to incorporate EBM thereby leading to 
better patient outcomes compared to NHS Trusts with less research activity 
(Harding et al., 2017, Cooper et al., 2019). A cross-sectional survey on the 
use of evidence-based medicine in health care professionals in France 
found that only 12% of pharmacist respondents reported using evidence-
based medicine compared to 22% of nurses and 36% of doctors (Lafuente-
Lafuente et al., 2019). The survey found that lack of critical appraisal skills 
was one of the most frequently reported reasons for not practising 
evidence-based medicine and “the profession was the only variable 
significantly associated with the declared degree of knowledge and use of 
EBM”(Lafuente-Lafuente et al., 2019). The participants in this student 
project corroborated this finding as they claimed to be able to critically 
appraise the primary literature, whereas they did not possess this skill 
before doing a PhD. 
 
Medicines are the most common intervention in the NHS (Royal 
Pharmaceutical Society, 2013). On the other hand, a study In two NHS 
hospitals found that 11.5% of hospital admissions were as a result of the 
adverse effects of medicines, half of which could have been prevented 
(Kongkaew et al., 2013). Pharmacists are trained to be experts in 
medicines, therefore, play an integral role in medicines optimisation 
ultimately leading to better patient outcomes and improving population 
health. The Pharmacy Integration fund set up in 2016 has contributed to 
the inclusion of pharmacists in novel care settings, e.g. general practice, 
care homes and integrated urgent care hubs (NHS England, 2018). Lord 
Carter’s report of 2016 proposed that hospital pharmacies increase the 
number of prescribing pharmacists and deploy more clinical pharmacists 
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both independently and as part of the multidisciplinary team to optimise 
medicine use (Lord Carter of Coles, 2016). This proposal highlights the 
need for pharmacists that are equipped to make evidence-based decisions 
to improve patient outcomes and also contribute to efficient use of NHS 
resources. 
 
5.5 Improved Pedagogy and Transferable skills. 
 
The findings from this project show that doing a PhD and engagement with 
the academic process made participants better educators, although self-
reported. This finding is in line with findings from other research that shows 
that pharmacy researchers have the potential to improve the education of 
pharmacy students (Kehrer and Svensson, 2012). In addition to the more 
obvious outcomes such as evidence-based clinical practice and increased 
competence in conducting research, doing a PhD conferred transferrable 
skills to participants. This finding echoes the findings from a study on 
doctoral candidates that doing a PhD confers skills that are transferable to 
different settings such as teamwork, organisation, management and the 
candidate can apply their specialist knowledge to broader concepts 
(Gokhberg et al., 2017).  
 
5.6 Future aspirations 
 
The post-doctoral intentions of clinicians doing a PhD are of interest as it 
could provide a surrogate measure of the future clinical academic 
workforce to teach the future generations of clinicians and a measure of 
research trained clinicians (Lopes et al., 2017). Research trained clinical 
pharmacists are in a unique position to develop hypotheses to investigate 
problems that would otherwise be imperceptible to other clinicians (Hall et 
al., 2017). Although participants in this study expressed the desire for a 
split job where they could maintain their clinical practice, they preferred to 
be full-time academics in the absence of a suitable split role. A definitive 
statement cannot be made regarding this due to social desirability bias. 
This objective could be further explored by using anonymous 
questionnaires to collect data. Furthermore, findings from this study 
suggest that there are not enough split clinical academic roles that 
compensate pharmacists at the appropriate pay grade. This finding is in 
line with another study which found that “there is no model clinical 
academic contract or guidance on pay and conditions” for health care 
professionals other than medics (Richardson et al., 2019).   
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5.7 Strengths and Limitations 
 
The strengths of this study are as follows: due to the highly educated 
nature of the group being investigated, most participants in the project were 
able to articulate their experiences succinctly during the interview, more 
participants had already completed their PhD than participants currently 
studying for one thereby allowing for narratives of the complete experience 
with the benefit of hindsight. 
 
Like all research, this project has some limitations. Participants in this 
project represented only twelve UK universities, so the results are not 
generalisable; 86.7% of participants were white compared to 46% of 
registered UK pharmacists(GPhC, 2019). There was no database to 
identify pharmacists that had unsuccessfully applied for NIHR funding and 
only one successful NIHR applicant responded to the interview invitation 
therefore not enough data was collected to meet the research objective of 
exploring the experiences of NIHR awardees. As the interviewer had 
previously made contact with participants via Twitter, there might have 
been an element of social desirability bias. 
 
5.8 Implications for pharmacists and policymakers 
 
There is potential for NHS pharmacists to contribute to research output 
excluding audits. Academic Pharmacy departments and employers should 
be aware of the challenges that pharmacists face in relation to PhD study. 
This awareness could inform the development of resources and structures 
to support the PhD students, possibly encouraging more clinical 
pharmacists to pursue a postgraduate degree, ultimately increasing the 
clinical academic pharmacist pipeline and enhancing the profession. 
    
5.9 Future research  
 
Further research should attempt to diversify participants and include more 
pharmacists that have applied for NIHR funding either successfully or 
unsuccessfully. Furthermore, an attempt should be made to reduce social 
desirability bias by using questionnaires or free text surveys to collect data 
regarding career aspirations anonymously. Ultimately, this research could 






Practising evidence-based medicine is crucial to running an efficient 
national health service. It endows economic benefits by using scarce 
resources efficiently, better outcomes to individual patients and improves 
population health. The integration of pharmacists into various levels of the 
health service and novel roles means that they are ideally placed to 
contribute their expertise to achieve optimal outcomes. It is widely touted 
that evidence-based medicine is a pillar of medicines optimisation, rightly 
leading to the assumption that pharmacists are trained to practise 
evidence-based medicine. The results from this project show that practising 
EBM is an advanced competency which is developed by research 
engagement and that the standard MPharm degree does not adequately 
equip clinical pharmacists with the skills required to incorporate this skill 
that is fundamental to their practice. 
 
Although there are funding sources exclusively available to pharmacist 
researchers and relatively easily accessible, the participants in this project 
have narrated that these funders do not eliminate the financial barrier to 
pursuing a research career. The NIHR is one funder that comprehensively 
eliminates the financial barriers to research participation. The main barrier 
to accessing NIHR funding is a lack of research experience, and due to 
traditional pharmacist job roles, pharmacists that are interested in a 
research career have to pro-actively seek opportunities to engage in 
research and develop their research portfolio to apply for these prestigious 
fellowships competitively. 
 
The findings of this project show that upon completing a PhD, most 
pharmacists will have to choose between academia and clinical practice. 
Taking into account the subtheme of monotony in clinical practice, most 
participants would likely choose a full-time academic career over a clinical 
career in the absence of a suitable split role. This outcome would not be 
ideal as there is a need to develop and retain a clinical academic workforce 
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Appendix 1  
 
What is clinical pharmacists experience of studying a PhD including NIHR 
fellowships and what does it lead to?  
 
Thank you for taking part in this interview, I really do appreciate the time you have given. 
Before we begin, I want to make it clear that if you wish to skip any question(s) during the 
interview, or if you want to stop the interview, all you have to do is say; you do not need to give 
any explanation for doing so. 
Are you happy to begin the interview? 
 
1. What is your current job? 
i. Which area of clinical pharmacy do you work in? 
ii. At what stage in your career did you become interested in research? 
 
2. Tell me about your research 
i. How/when did you get your first research experience 
ii. What experience of research did you have prior to PhD – ICAP, mentors, 
publication, service evaluation, clinical audit etc 
 
3. Can you tell me about your PhD experience? 
i. What key challenges have you experienced so far/ did you experience? 
ii. Are there any personal attributes/institutional features that helped you 
overcome these challenges? 
iii. What benefit have you derived from PhD study? 
 
4. What motivates you to undertake a PhD/professional doctorate? 
i. Can you talk about primary and secondary motivations? 
ii. Passion for research vs increasing employability. 
 
 
5. How was your PhD funded? / how is your PhD being funded? 
 
i. Did you apply for or consider applying for any research fellowships such as NIHR?  
ii. If yes – why, if no – why not? 
iii. Was it challenging to secure funding? 
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6. Future Career 
i. What are your career aspirations? 
ii. Do you use your research skills at your job? 
iii. Moving forward, how do you expect your practice will be affected by the PhD/ 
how has your practice been affected. 
 
Thank you for your time.
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Appendix 3 
 
